Scott Coiante News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Agile Therapeutics, Inc (NASDAQ:AGRX) Q3 2023 Earnings Call Transcript

Operator: Good morning, and welcome to the Agile Therapeutics Third Quarter 2023 Financial Results Conference Call. Please note, today s event is being recorded.

Scott coianteMatt rileyOren livnatAl altomariAlfred altomariAmy welshAgile therapeutics incTwentyeight healthAgile therapeuticsCall transcript novemberAgile therapeutics third quarterResults conferenceChief executive officerChief financialChief commercial officerInvestor relations

Agile Therapeutics Reports an Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4)

04.10.2023 - PRINCETON, N.J., Oct. 04, 2023 (GLOBE NEWSWIRE) - Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced the granting of a previously disclosed inducement award to the Company’s newly appointed Chief Financial .

Scott coianteAgile therapeutics incCompany compensation committeeChief financial officerNasdaq listing ruleCompensation committeeAgile therapeuticsAgile therapeutics registered old chartGile therapeutics registered old kursGile therapeutics registered old aktie

Agile Therapeutics Reports an Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4)

Agile Therapeutics Reports an Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4)
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

Matt rileyScott coianteAboutagiletherapeutics incHead of investor relations corporate communicationsAgile therapeutics incCompany compensation committeeAgile therapeuticsChief financial officerNasdaq listing ruleCompensation committeeInvestor relations

Agile Therapeutics Reports an Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4)

Agile Therapeutics, Inc (NASDAQ:AGRX) Q2 2023 Earnings Call Transcript

Agile Therapeutics, Inc. (NASDAQ:AGRX) Q2 2023 Earnings Call Transcript August 9, 2023 Agile Therapeutics, Inc. beats earnings expectations. Reported EPS is $-3.1, expectations were $-3.48. Operator: Good morning, and welcome to the Agile Therapeutics Second Quarter of 2023 Financial Results Conference Call. Please note today’s event is being recorded. I would now like to turn […]

Scott coianteAl altomariAlbina glisic shutterstockAmy welshWomen healthTwentyeight healthPaying government jobs without